Research

On this page you will find articles and links to current research into or related to Attention Deficit/Hyperactivity Disorder. This is provided to give you the visitor information as to what is currently being done in this area. It only contains information about research that we know of and does not constitute a complete list of everything going on in this field. Please also note that by providing this information, it does not necessarily mean that adders.org or Thanet ADDers agree or disagree with any article.

Click on one the headings below or scroll down to read:

Serotonin May Hold Key to Hyperactivity Disorder Disorder Treatment

Paying Attention

Treating Children's Sleep Disorders Improves Attention Deficit Symptoms

Serotonin May Hold Key to Hyperactivity Disorder Disorder Treatment

The following is an extract from Howard Hughes Medical Institute News. Please visit their web site for more information.

January 15, 1999—Much concern has been raised over prescribing Ritalin® or other stimulants to control hyperactivity disorders in children. Relatively little is known about the long-term effects of these stimulants or how they alter brain chemistry.

Researchers at the Howard Hughes Medical Institute at Duke University have discovered that Ritalin® and other stimulants exert their paradoxical calming effects by boosting serotonin levels in the brain. Elevating serotonin appears to restore the delicate balance between the brain chemicals dopamine and serotonin and calms hyperactivity, says HHMI investigator Marc Caron at Duke University Medical Center. Caron is an author of the study published in the January 15, 1999, issue of the journal Science.

Attention deficit hyperactivity disorder (ADHD) affects three to six percent of school-aged children. Symptoms include restlessness, impulsiveness, and difficulty concentrating. Stimulants commonly used to treat ADHD are so effective that "researchers haven't really taken the time to investigate how they work," says Caron.

Previous dogma, says Caron, held that the calming action of Ritalin® works through the neurotransmitter dopamine. Specifically, researchers believed that Ritalin® and other stimulants interact with the dopamine transporter protein (DAT), a housekeeper of sorts for nerve pathways. After a nerve impulse moves from one neuron to another, DAT removes residual dopamine from the synaptic cleft-the space between two neurons-and repackages it for future use.

Caron's team suspected that dopamine wasn't the only key to understanding ADHD, so they turned to mice in which they had "knocked out" the gene that codes for DAT. Since there is no DAT to "mop up" dopamine from the synaptic cleft, the brains of the mice are flooded with dopamine. The excess dopamine causes restlessness and hyperactivity, behaviors that are strikingly similar to those exhibited by children with ADHD.

When placed in a maze that normal mice negotiate in less than three minutes, the knockout mice became distracted-performing extraneous activities such as sniffing and rearing-and they failed to finish in less than five minutes. The knockout mice also seemed unable to suppress inappropriate impulses-another hallmark of ADHD.

Surprisingly, the knockout mice were still calmed by Ritalin®, Dexedrine® and other stimulants even though they lacked the protein target on which Ritalin® and Dexedrine® were thought to act. "That caused us to look for other systems that these stimulants might affect," says Caron.

To test whether the stimulants interact with dopamine through another mechanism, the researchers administered Ritalin® to the normal and knockout mice and monitored their brain levels of dopamine. Ritalin® boosted dopamine levels in the normal mice, but it did not alter dopamine levels in knockout mice. That result implied that "Ritalin® could not be acting on dopamine," says Caron.

Next, the researchers gave the knockout mice a drug that inactivates the norepinephrine transport protein. With transport disabled, norepinephrine levels increased as expected, but the boost in norepinephrine did not ameliorate the symptoms of ADHD as it should. This suggested to Caron's team that Ritalin® exerted its effects through another neurotransmitter.

They then studied whether the stimulants altered levels of the neurotransmitter serotonin. The scientists administered Prozac®-a well-known inhibitor of serotonin reuptake-to the knockout mice. After ingesting Prozac®, the knockout mice showed dramatic declines in hyperactivity.

"This suggests that rather than acting directly on dopamine, the stimulants create a calming effect by increase serotonin levels," Caron says.

"Our experiments imply that proper balance between dopamine and serotonin are key," says Raul Gainetdinov, a member of Caron's research team. "Hyperactivity may develop when the relationship between dopamine and serotonin is thrown off balance."

The brain has 15 types of receptors that bind to serotonin, and Gainetdinov is now trying to determine which specific serotonin receptors mediate the effects of Ritalin®.

The hope, says Caron, "is that we can replace Ritalin® with a very specific compound that targets a single subset of receptors." While Prozac® calmed hyperactivity in the knockout mice, Gainetdinov says that "Prozac® isn't the best, because it isn't very selective." Caron and Gainetdinov are optimistic that a new generation of compounds that interact more specifically with the serotonin system will prove to be safer and more effective for treatments for ADHD.

[Back To Top Menu]

Paying Attention

The following are extracts from the Scientific American website in an "In Focus" article, entitled "Paying Attention". Please visit their website for the full article.

Another facet of ADHD malfunctioning comes from positron emission tomography (PET) studies. Julie B. Schweitzer of Emory University monitored brain activity in ADHD and unaffected men while they completed a task. Participants heard a series of numbers, one every 2.4 seconds, and were asked to add the last two digits they heard. Looking at the PET scans, Schweitzer saw two major differences between the groups. First, the ADHD individuals maintained high levels of blood flow, whereas the controls displayed deactivation in the temporal gyrus region-indicating some kind of learning."

Our thanks to Carol T. for bringing this to our attention.

[Back To Top Menu]

Treating Children's Sleep Disorders Improves Attention Deficit Symptoms

Walters said the benefits of the levodopa appear to last long term. The next step to confirm these results is a double-blind, placebo-control trial, he said. The drug should also be tested with children with ADHD who do not have these sleep disturbances, he said. Our thanks to Kathy West for bringing this to our attention.

COMMENT

As to Ritalin, the stimulating effect, boosts the immature inhibitory function on the left hemisphere giving the patient on treatment better "brakes". When many young A.D.H.D patients are given a sedative the opposite takes place. That is, they are stimulated and hyperactivity gets worse. Clearly the inhibitory centers on the left hemisphere are sedated with fewer "brakes" and more activity takes place. This is the well known "paradoxical reaction" often seen, to medications, in these children. ADHD must be seen as an over developed right hemisphere giving behavior problems or and immaturity of the left hemisphere giving rise to learning problems or a mixture of both in varying degrees." [Back To Top Menu]